Jefferson Abington Hospital is the flagship hospital of Jefferson Health–Abington, located in Abington Township, Montgomery County, Pennsylvania, in the northern suburbs of Philadelphia.

There are 665 beds in Abington Memorial Hospital.

During the past decade, Abington Memorial Hospital conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 137 clinical trials were completed, i.e. on average, 207.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 51 clinical trials were completed. i.e. 728.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Abington Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "Gynecologic Oncology Group" with 77 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "GOG Foundation" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 106 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Abington Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 133 trials as a collaborator, "NRG Oncology" with 49 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "Radiation Therapy Oncology Group" with 7 trials as a collaborator. Other collaborators include 139 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Abington Memorial Hospital" are "Ovarian Cancer" (26 trials), "Recurrent Ovarian Carcinoma" (23 trials), "Primary Peritoneal Cavity Cancer" (18 trials), "Recurrent Fallopian Tube Carcinoma" (18 trials) and "Recurrent Primary Peritoneal Carcinoma" (17 trials). Many other conditions were trialed in "Abington Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Abington Memorial Hospital" are "Drug" (220 trials), "Other" (125 trials), "Biological" (68 trials), "Radiation" (45 trials) and "Procedure" (42 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (80 trials), "Quality-of-Life Assessment" (41 trials), "Paclitaxel" (33 trials), "Carboplatin" (23 trials) and "cisplatin" (21 trials). Other intervention names were less common.

The vast majority of trials in "Abington Memorial Hospital" are 161 trials for "Female" genders, 131 trials for "All" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Abington Memorial Hospital". undefined are not yet recruiting, 12 are recruiting, 80 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 155 completed trials in Abington Memorial Hospital, 2 suspended trials, and 45 terminated clinical trials to date.

Out of the total trials that were conducted in Abington Memorial Hospital, 3 "Phase 1" clinical trials were conducted, 129 "Phase 2" clinical trials and 131 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 26 trials that are defined as “Not Applicable".

Abington Memorial Hospital has several departments that took part in Clinical trials: "Asplundh Cancer Pavilion" - 53 trials, "Rosenfeld Cancer Center at Abington Memorial Hospital" - 44 trials, "Abington Memorial Hospital-Asplundh Cancer Pavilion" - 6 trials, "Abington Hematology Oncology" - 2 trials, "Abington Mem Hosp-Abington; Rose. Can Ctr,Gyn Onc Ins" - 2 trials